Artificial intelligence is reshaping medicine fast enough that who benefits from it is no longer a hypothetical question, and President Lee Jae-myung used a message to a major health summit in Seoul this week to argue the answer should be decided on purpose rather than left to chance.
A summit built around a shared declaration
The occasion was the World Bio Summit 2026, held in Seoul over Wednesday and Thursday and co-hosted by the World Health Organization alongside the Korean government, a pairing that gave the gathering both a domestic platform and international weight. Lee was not present in person. His senior secretary for social affairs, Kim Kyoung-ja, delivered his remarks on his behalf, reading out a message aimed less at a single policy announcement than at setting a tone for how AI in medicine should be governed going forward.
The core argument: safe deployment as a global equity issue
The thrust of Lee's message was that AI technology should be used safely and responsibly to bridge gaps in medical services worldwide, language that frames responsible deployment not as a technical afterthought but as the condition under which AI's benefits actually reach the people who need them most. He tied that point directly to a broader equity argument, saying that narrowing gaps between countries in the health care sector and guaranteeing universal access to adequate medical services will require collective international action rather than any one country acting alone.
A declaration meant to outlast the summit
The summit's concrete output was the adoption of what organizers are calling the AI Healthcare Seoul Declaration, a statement committing signatories to ensuring that the gains from AI innovation in medicine reach all populations through safe and responsible application rather than concentrating in wealthier health systems that can afford to adopt the technology first.
Whether a declaration changes outcomes on the ground is, as with most summit statements, a separate question from whether it was adopted. But the choice to anchor the Seoul gathering around a named declaration, rather than a loose set of talking points, signals an attempt to give the equity argument something concrete to be measured against as AI tools spread through health systems at very different stages of development.
